STAT3 and lung carcinoma: CUR treatment resulted in reduced cell proliferation in a dose‐dependent manner for the H441 cells. These findings indicate that CUR can suppress the activity of the Stat3 pathway in lung cancer‐derived cells, leading to a reduction in cell proliferation.